Michael Schurr

Associate Professor

University of Denver

United States

Research Interests

Explore related searches

Professors in United States Professors in Microbiology Microbiology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael Schurr is an Associate Professor at the University of Colorado Denver. His research focuses on the veterinary and medical implications of Corynebacterium bovis , particularly in immunocompromised models and the gastrointestinal health of laboratory animals. He has published recent articles exploring the effects of antimicrobial treatment and environmental factors on microbial health. His work contributes to the understanding of bacterial interactions and their implications in clinical and dental settings.

Articles (17)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Devatha Nair

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

Nalinikanth Kotagiri

UNITED STATES

View details

Jeffrey Stansbury

University of Colorado Boulder

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Schurr

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

A Clinical Scoring System and Impact of Athymic Nude Mouse Age on Corynebacterium bovis Clinical Disease

Antibiotic Treatment of <i>Corynebacterium bovis</i>-associated Clinical Disease in NSG Mice

Effects of Extended Cage Component Sanitation Interval on the Microenvironment, Health, and Gastrointestinal Microbiome of Rats (Rattus norvegicus)

Effect of Antimicrobial Prophylaxis on <i>Corynebacterium bovis</i> Infection and the Skin Microbiome of Immunodeficient Mice.

Effect of Antimicrobial Prophylaxis on Corynebacterium bovis Infection and the Skin Microbiome of Immunodeficient Mice

A Clinical Scoring Systems for the Evaluation of Corynebacterium bovis-associated Disease in NSG Mice

Synthesis, characterization and evaluation of azobenzene nanogels for their antibacterial properties in adhesive dentistry

Synthesis, characterization and evaluation of azobenzene nanogels for their antibacterial properties in adhesive dentistry.

Correction to: Bacterial reduction effect of four different dental lasers on titanium surfaces in vitro.

Bacterial reduction effect of four different dental lasers on titanium surfaces in vitro.

The Bactericidal Tandem Drug, AB569: How to Eradicate Antibiotic-Resistant Biofilm <i>Pseudomonas aeruginosa</i> in Multiple Disease Settings Including Cystic Fibrosis, Burns/Wounds and Urinary Tract Infections.

Antimicrobial Susceptibility of <i>Corynebacterium bovis</i> Isolates from Immunodeficient Rodents.

AB569, a non-toxic combination of acidified nitrite and EDTA, is effective at killing the notorious Iraq/Afghanistan combat wound pathogens, multi-drug resistant Acinetobacter baumannii and Acinetobacter spp.

Bacterial reduction effect of four different dental lasers on titanium surfaces in vitro (Jul, 10.1007/s10103-021-03349-3, 2021)

Metaphylactic Antibiotic Treatment to Prevent the Transmission of <i>Corynebacterium bovis</i> to Immunocompromised Mouse Offspring.

Selective Inhibition of Streptococci Biofilm Growth via a Hydroxylated Azobenzene Coating.

Pseudomonas aeruginosa Alginate Benefits Staphylococcus aureus?

Collaborators (3)

Devatha Nair

Nalinikanth Kotagiri

Jeffrey Stansbury

Make your next move.